Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma
Clinical trial NCT07050186 · RECRUITING
Trial details
- NCT number
- NCT07050186
- Sponsor
- Northwestern University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-15
- Primary completion
- 2030-11-20
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.